Cancer patients who got a COVID shot lived significantly longer. No, that’s not a typo. A new study found that a…
Summary
A study of over 1,000 cancer patients found that receiving an mRNA COVID vaccine within 100 days of starting immunotherapy dramatically improved survival rates—nearly doubling survival time in lung cancer (20.6 to 37.3 months) and skin cancer (26.7 to 40 months). mRNA vaccines stimulate the immune system to enhance the body's ability to attack tumors, particularly helping patients who typically don't respond well to traditional immunotherapy.
Summarized by ThreadOut AI from the full thread. May miss nuance — read the thread below.
- #1
- #2
- #3
- #4
- #5
- #6
- #7
- #8
- #9
- #10